BEIJING SHENGYIYAO SCIENCE & TECHNOLOGY DEVELOPMENT CO.; LTD
发明人:
LI, XINJIAN,HONG, HONG,LU, GE
申请号：
CA2758820
公开号：
CA2758820C
申请日:
2010.04.14
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
A targeted sustained-release microsphere vascular embolizing agent, theproduction method and the use thereof are disclosed. The microsphere comprisessodium alginate as the carrier and sorafenib as the targeted anti-tumormedicineand sorafenib is encapsulated by sodium alginate. The weight ratio ofsorafenib tosodium alginate is 1:1-1:30. The microspheres are used for manufacturingmedicament for the treatment of solid tumors with advantages including highmedicine concentration in the target regions with reduced systemic dosage andtoxic and side effects.
